Table of Contents
Introduction
Ramipril is an angiotensin-converting enzyme (ACE) inhibitor widely used in hypertension, heart failure, diabetic nephropathy, and cardiovascular risk reduction. It lowers blood pressure by inhibiting formation of angiotensin II and reducing aldosterone secretion. Ramipril also increases bradykinin levels, contributing to vasodilation and cardiovascular protection.
Mechanism of Action (Step-wise)
- Ramipril is administered as a prodrug.
- It is converted in the liver to its active metabolite, ramiprilat.
- Ramiprilat inhibits angiotensin-converting enzyme (ACE).
- ACE normally converts angiotensin I into angiotensin II.
- Inhibition of ACE decreases formation of angiotensin II.
- Reduced angiotensin II decreases vasoconstriction.
- Systemic vascular resistance and blood pressure decrease.
- Lower angiotensin II levels also reduce aldosterone secretion from the adrenal cortex.
- Reduced aldosterone decreases sodium and water retention.
- Ramipril additionally inhibits degradation of bradykinin.
- Increased bradykinin enhances nitric oxide and prostaglandin-mediated vasodilation.
- Cardiac preload and afterload decrease, improving heart function.
- Reduced intraglomerular pressure helps protect renal function in diabetic nephropathy.
- The overall effect is vasodilation, reduced blood pressure, and cardiovascular protection.
A key exam point is that ramipril inhibits ACE, decreasing angiotensin II formation and increasing bradykinin levels.
Pharmacokinetics
Ramipril is administered orally and is well absorbed. It is converted hepatically into ramiprilat, the active metabolite. Ramiprilat has a relatively long duration of action, allowing once-daily dosing in many patients. Elimination occurs mainly through the kidneys.
Clinical Uses
Ramipril is used in hypertension, heart failure, post-myocardial infarction management, diabetic nephropathy, and cardiovascular risk reduction. It is also beneficial in slowing progression of chronic kidney disease.
Adverse Effects
Common adverse effects include dry cough, hypotension, dizziness, and hyperkalemia. Rare but serious adverse effects include angioedema and acute kidney injury. Ramipril is contraindicated in pregnancy because of fetal toxicity.
Comparative Analysis
| Feature | Ramipril | Losartan | Amlodipine |
|---|---|---|---|
| Drug class | ACE inhibitor | ARB | Calcium channel blocker |
| Main target | ACE enzyme | AT1 receptor | L-type calcium channels |
| Bradykinin effect | Increased | No effect | No effect |
| Dry cough risk | Common | Rare | Rare |
| Hyperkalemia risk | Present | Present | Minimal |
| Renal protective effect | Strong | Strong | Moderate |
Ramipril differs from losartan because it increases bradykinin levels, which contributes to cough and angioedema risk. Compared with amlodipine, ramipril directly suppresses the renin-angiotensin-aldosterone system.
MCQs
- Ramipril belongs to which drug class?
a) ARBs
b) ACE inhibitors
c) β blockers
d) Calcium channel blockers
Answer: b) ACE inhibitors
- Ramipril is converted into which active metabolite?
a) Enalaprilat
b) Ramiprilat
c) Losartan
d) Captopril
Answer: b) Ramiprilat
- ACE normally converts:
a) Angiotensin II to angiotensin I
b) Angiotensin I to angiotensin II
c) Aldosterone to renin
d) Bradykinin to nitric oxide
Answer: b) Angiotensin I to angiotensin II
- Ramipril decreases levels of:
a) Bradykinin
b) Angiotensin II
c) Nitric oxide
d) Prostaglandins
Answer: b) Angiotensin II
- Reduced angiotensin II causes:
a) Vasoconstriction
b) Vasodilation
c) Tachycardia only
d) Bronchospasm
Answer: b) Vasodilation
- Ramipril reduces secretion of:
a) Insulin
b) Aldosterone
c) Thyroxine
d) Histamine
Answer: b) Aldosterone
- A common adverse effect is:
a) Dry cough
b) Hypercalcemia
c) Bradykinesia
d) Hyperglycemia
Answer: a) Dry cough
- Ramipril may increase risk of:
a) Hypokalemia
b) Hyperkalemia
c) Hypernatremia
d) Hypoglycemia
Answer: b) Hyperkalemia
- Ramipril protects kidneys mainly by reducing:
a) Intraglomerular pressure
b) Blood glucose
c) Calcium excretion
d) Histamine release
Answer: a) Intraglomerular pressure
- Ramipril increases levels of:
a) Bradykinin
b) Dopamine
c) Histamine
d) Acetylcholine
Answer: a) Bradykinin
- A serious adverse effect of ramipril is:
a) Angioedema
b) Cataracts
c) Hyperthyroidism
d) Migraine
Answer: a) Angioedema
- Ramipril is contraindicated in:
a) Asthma
b) Pregnancy
c) Migraine
d) Hyperlipidemia
Answer: b) Pregnancy
FAQs
What is the mechanism of action of ramipril?
Ramipril inhibits ACE, reducing angiotensin II formation and increasing bradykinin levels.
Why does ramipril lower blood pressure?
Because it causes vasodilation and reduces sodium and water retention.
Why can ramipril cause dry cough?
Due to accumulation of bradykinin.
What is the major renal benefit of ramipril?
Reduction of intraglomerular pressure and slowing progression of nephropathy.
Why is ramipril contraindicated in pregnancy?
Because ACE inhibitors can cause fetal renal damage and developmental abnormalities.
How does ramipril differ from ARBs?
ACE inhibitors increase bradykinin levels, while ARBs do not.
References
Goodman & Gilman’s The Pharmacological Basis of Therapeutics – Drugs Affecting the Renin-Angiotensin System
https://accessmedicine.mhmedical.com/book.aspx?bookid=3191
Katzung: Basic and Clinical Pharmacology – ACE Inhibitors and ARBs
https://accessmedicine.mhmedical.com/content.aspx?bookid=3382
Tripathi: Essentials of Medical Pharmacology – Antihypertensive Drugs
https://www.jaypeedigital.com
Harrison’s Principles of Internal Medicine – Hypertension and Heart Failure
https://accessmedicine.mhmedical.com
